Trevi Therapeutics Inc

+0.08 (+3.70%)
5:48:07 PM EDT: $2.24 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Trevi Therapeutics Inc Stock, NASDAQ:TRVI

195 Church Street, 14th floor, New Haven, Connecticut 06510
United States of America
Phone: +1.203.304.2499
Number of Employees: 25


Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson�s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.